Monte Rosa Therapeutics Inc Stock Performance
as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
$6.06$7.4
12.43%
Downside
6.94%
Upside
52 Week's Low
52 Week's High
$3.5$12.449.42%
Downside
79.19%
Upside
Monte Rosa Therapeutics Inc share price movements today
- Previous Close
- $4.81
- Open
- $7.17
- Volume
- 21.7M
- Day's Low - High
- $6.06 - $7.4
- 52 Week Low - High
- $3.5 - $12.4
Monte Rosa Therapeutics Inc Historical Returns
- 1 Month Return
- + 5.02 %
- 3 Month Return
- -2.04 %
- 1 Year Return
- -20.89 %
- 3 Year Return
- -39.72 %
- 5 Year Return
- 0 %
Monte Rosa Therapeutics Inc Stock Fundamentals & Key Indicators
Check Monte Rosa Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$297.1M
EPS (TTM)
-0.0909
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
12.33
Industry PE ratio
-3.8535542168674697
P/B Ratio
12.3333
PEG Ratio
0EBITDA
23.3M
Revenue (TTM)
178.0M
Profit Margin
13.58%
Return On Equity TTM
9.81%
Monte Rosa Therapeutics Inc Stock Valuation
Track how Monte Rosa Therapeutics Inc P/E has moved over time to understand its valuation trends.
Monte Rosa Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Today (12.33x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: 12.33x
Monte Rosa Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Monte Rosa Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $297.1M | NA | 12.33 | 13.58% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Monte Rosa Therapeutics Inc Stock including INR - Dollar returns
The Monte Rosa Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Monte Rosa Therapeutics Inc investment value today
Current value as on today
₹1,18,801
Returns
₹18,801
(+18.8%)
Returns from Monte Rosa Therapeutics Inc Stock
₹13,816 (+13.82%)
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Monte Rosa Therapeutics Inc Stock
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Monte Rosa Therapeutics Inc. Average target price of $15.29
Monte Rosa Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Monte Rosa Therapeutics Inc.
What analysts predicted
54.74%UPSIDE
Target Price
$15.29
Current Price
$6.92
Analyzed by
14 Analysts
Target
$15.29
Monte Rosa Therapeutics Inc target price $15.29, a slight upside of 54.74% compared to current price of $6.92. According to 14 analysts rating.
Monte Rosa Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Monte Rosa Therapeutics Inc Stock has increased by 200% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:200% versus previous 30 day period
Monte Rosa Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Monte Rosa Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Monte Rosa Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Monte Rosa Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc News & Key Events
Today's Timeline - 15 September
Mon, 08:59 PM
-Monte Rosa announces collaboration with Novartis for novel degraders, receiving $120 million upfront and potential total payments of $5.7 billion.
Insights on Monte Rosa Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, GLUE stock has moved up by 43.5%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 119.8%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 47.3%
About Monte Rosa Therapeutics Inc
| Organisation | Monte Rosa Therapeutics Inc |
| Headquarters | 321 Harrison Avenue, Boston, MA, United States, 02118 |
| Industry | Services |
| CEO | Dr. Markus Warmuth M.D. |
| E-voting on shares | Click here to vote |
Key Management of Monte Rosa Therapeutics Inc
Name | Title |
|---|---|
Mr. Andrew Funderburk | Senior VP and Head of IR & Strategic Finance |
Dr. Markus Warmuth M.D. | President, CEO & Director |
Mr. Filip Janku M.D., Ph.D. | Chief Medical Officer |
Ms. Jennifer Champoux | Chief Operating Officer |
Dr. John C. Castle Ph.D. | Chief Data & Information Officer |
Mr. Philip Nickson J.D., Ph.D. | Chief Business & Legal Officer |
Dr. Sharon Townson Ph.D. | Chief Scientific Officer |
Mr. Magnus Walter DPHIL | Senior Vice President of Drug Discovery |
Mr. Edmund Dunn | Senior VP & Corporate Controller |
FAQs
What is Monte Rosa Therapeutics Inc share price today?
Monte Rosa Therapeutics Inc share price today is $6.92 as on at the close of the market. Monte Rosa Therapeutics Inc share today touched a day high of $7.4 and a low of $6.06.
What is the 52 week high and 52 week low for Monte Rosa Therapeutics Inc share?
Monte Rosa Therapeutics Inc share touched a 52 week high of $12.4 on and a 52 week low of $3.5 on . Monte Rosa Therapeutics Inc stock price today i.e. is closed at $6.92,which is 44.19% down from its 52 week high and 97.71% up from its 52 week low.
What is Monte Rosa Therapeutics Inc's market capitalisation today?
Monte Rosa Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Monte Rosa Therapeutics Inc Stock (GLUE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Monte Rosa Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Monte Rosa Therapeutics Inc Shares that will get you 0.2168 shares as per Monte Rosa Therapeutics Inc share price of $6.92 per share as on September 16, 2025 at 1:29 am IST.
What is the minimum amount required to buy Monte Rosa Therapeutics Inc Stock (GLUE) from India?
Indian investors can start investing in Monte Rosa Therapeutics Inc (GLUE) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Monte Rosa Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Monte Rosa Therapeutics Inc share’s latest price of $6.92 as on September 16, 2025 at 1:29 am IST, you will get 1.4451 shares of Monte Rosa Therapeutics Inc. Learn more about
fractional shares .